Haidar Yassin, MD
Interventional Cardiology · Phoenix, AZNPI 1659532000
Payments from drug & device makers
Across 857 payments — averaging $533.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$267K
- Boston Scientific$97K
- Abbott$31K
- EKOS Corporation$23K
- Medtronic$16K
- W. L. Gore & Associates, Inc.$10K
- plus $13K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 324 | $267,349 |
| Boston Scientific | 173 | $96,835 |
| Abbott | 78 | $30,609 |
| EKOS Corporation | 41 | $22,712 |
| Medtronic(2 entities) | 99 | $16,266 |
| W. L. Gore & Associates, Inc. | 26 | $9,660 |
| Penumbra, Inc. | 24 | $4,667 |
| Abiomed | 36 | $3,317 |
| Inari Medical, Inc. | 7 | $1,824 |
| Imperative Care, Inc | 3 | $413 |
| Shockwave Medical, Inc | 2 | $411 |
| Philips North America LLC | 3 | $297 |
| Teleflex LLC | 3 | $287 |
| Amgen | 5 | $215 |
| AstraZeneca | 1 | $212 |
| Terumo Medical Corporation | 3 | $199 |
| Heartflow, Inc. | 3 | $184 |
| Stryker | 1 | $181 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $167 |
| Livanova USA, Inc. | 1 | $156 |
| Biotronik Inc. | 1 | $123 |
| E.r. Squibb & Sons, L.L.C. | 1 | $119 |
| Atricure, Inc. | 1 | $114 |
| B. Braun Interventional Systems Inc. | 1 | $105 |
| Asahi Intecc USA, Inc. | 1 | $89 |
| Novartis | 4 | $86 |
| Chiesi USA, Inc. | 3 | $60 |
| Johnson & Johnson | 3 | $57 |
| Saranas, Inc. | 2 | $48 |
| Sanofi-aventis U.S. LLC | 2 | $32 |
| CSL Behring | 1 | $20 |
| BTG International Inc. | 1 | $12 |
How this compares
$456,827 in reported general payments places this provider in the 90th percentile of 223 interventional cardiology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Phoenix
- Paul SorajjaPhoenix$8.8M
- Timothy ByrnePhoenix$2.1M
- Mohamad LazkaniPhoenix$1.1M
- Parminder SinghPhoenix$854K
- Akil LoliPhoenix$506K
- Michael WhitePhoenix$417K
- Nezar FallujiPhoenix$348K
- Floyd FortuinPhoenix$263K
- Nishant GuptaPhoenix$196K
- Madhavagopal CherukuriPhoenix$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.